Name | 3-[7,12,17-tris(2-carboxyethyl)-3,8,13,18-tetramethyl-21,22-dihydroporphyrin-2-yl]propanoic acid |
---|---|
Synonyms |
Coproporphyrin I
coproporphyrin-I tetracarboxylic acid coproporphyrine I coproporphyrin I-3,8,13,18-tetramethyl-21H,23H-porphine-2,7,12,17-tetrapropionic acid 3,8,13,18-tetramethyl-21H,23H-porphyrin 2,7,12,17-tetrapropionic acid 3,8,13,18-Tetramethyl-21H,23H-porphine-2,7,12,17-tetrapropionic acid |
Description | Coproporphyrin I is an endogenous metabolite present in Urine and Blood that can be used for the research of Liver Disease and Porphyria[1][2][3][4]. |
---|---|
Related Catalog | |
In Vitro | Endogenous metabolites is defined as those that are annotated by Kyoto Encyclopedia of Genes and Genomes as substrates or products of the ~1900 metabolic enzymes encoded in our genome. It is clear in the body of literature that there are documented toxic properties for many of these metabolites[1]. |
References |
Molecular Formula | C36H38N4O8 |
---|---|
Molecular Weight | 654.70900 |
Exact Mass | 654.26900 |
PSA | 205.50000 |
LogP | 3.09360 |
Index of Refraction | 1.638 |
Precursor 9 | |
---|---|
DownStream 1 | |